Amanote Research

Amanote Research

    RegisterSign In

Bioavailability of Diphenylhydantoin

Clinical Pharmacology and Therapeutics - United States
doi 10.1002/cpt1974164727
Full Text
Open PDF
Abstract

Available in full text

Categories
Pharmacology
Date

October 1, 1974

Authors
Kenneth S. AlbertErmelinda SakmarMargarette R. HallmarkDonald J. WeidlerJohn G. Wagner
Publisher

Wiley


Related search

Biopharmaceutical Studies on Hydantoin Derivatives. IV. Factors Affecting Bioavailability of 5,5-Diphenylhydantoin in Dog.

Journal of Pharmacobio-Dynamics
1984English

Diphenylhydantoin Induced DRESS Syndrome: A Case Report

Turkish Journal of Anesthesia and Reanimation
2014English

Diphenylhydantoin and Potassium Transport in Isolated Nerve Terminals

Journal of Clinical Investigation
Medicine
1971English

Interactions of Diphenylhydantoin and Cardiac Glycosides on Atrial Potassium

American Journal of Physiology-Legacy Content
1976English

Bioavailability of Phytochemicals

2012English

Influence of Diphenylhydantoin on Electrophysiological Properties of the Canine Heart

Circulation Research
Cardiovascular MedicinePhysiologyCardiology
1967English

Acute Diphenylhydantoin and Primidone Poisoning Treated by Peritoneal Dialysis.

Journal of Neurology, Neurosurgery and Psychiatry
PsychiatryMental HealthNeurologySurgery
1968English

The Bioavailability of Digoxin

The Lancet
Medicine
1972English

Bioavailability of Sublingual Ergotamine.

British Journal of Clinical Pharmacology
Pharmacology
1982English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy